SCHEMBL369360

SCHEMBL369360

CCOC(=O)c1cn(Cc2ccc(OC)cc2)nc1C(O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
ALDH1A1 P00352 6/20 0.47
LMNA P02545 4/20 0.47
ADORA1 P30542 1/20 0.45
KMT2A Q03164 5/20 0.44
KDM4E B2RXH2 3/20 0.43
HPGD P15428 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
USP2 O75604 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 4/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29975109 0.84 MAPT (0.47) MAPTALDH1A1LMNAADORA1KMT2A
SCHEMBL1052418 0.82 PDE4D (0.49) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL369164 0.80 ALDH1A1 (0.48) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL370028 0.79 KMT2A (0.53) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL25191628 0.79 MAPT (0.47) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL369424 0.79 UCHL1 (0.47) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL2507978 0.79 MAPT (0.47) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL3356514 0.78 MAPT (0.46) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL2508034 0.78 MAPT (0.46) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL6036261 0.78 ALDH1A1 (0.54) ALDH1A1LMNAKMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS BOLEA CHRISTELLE (CH) 2013-08-15 US disclosed
EP-2595986-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Addex Pharma SA (CH) 2013-05-29 EP disclosed
WO-2012009009-A2 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210809-A1 NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS GRM2, GRM4, GRM1 MAPT 971/4885ALDH1A1 2554/4885LMNA 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.